A study of TNF-α, TGF-β, IL-10, IL-6, and IFN-γ gene polymorphisms in patients with depression

Journal of Neuroimmunology

Volumn 293, Issue , 2016, Pages 123-128

  Mihailova, Snezhina ^a   Ivanova Genova, Elena ^a   Lukanov, Tzvetelin ^a   Stoyanova, Vesela ^a   Milanova, Vihra ^a   Naumova, Elissaveta ^a  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Bulgarians; Cytokine gene polymorphism; Depression; Disease course; Susceptibility

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GAMMA INTERFERON GENE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENOTYPE; HUMAN; INTERLEUKIN 10 GENE; INTERLEUKIN 6 GENE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TUMOR NECROSIS FACTOR ALPHA GENE; TUMOR NECROSIS FACTOR BETA GENE; ADOLESCENT; ADULT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; NONPARAMETRIC TEST; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ADULT; CYTOKINES; DEPRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 84961213096     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2016.03.005     Document Type: Article

References (48)

1. Awad M.R., El-Gamel A., Hasleton P., Turner D.M., Sinnott P.J., I.V.Hutchinson Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998, 66:1014-1020.
2. Bamoulid J., Courivaud C., Deschamps M., Gaugler B., Tiberghien P., Chalopin J.M., Saas P., Ducloux D. The interleukin-6 gene promoter polymorphism -174 and atherosclerotic events in overweight transplanted patients. J. Transplant. 2011, (803429).
3. Bob P., Raboch J., Maes M., Susta M., Pavlat J., Jasova D., Vevera J., Uhrova J., Benakova H., Zima T. Depression, traumatic stress and interleukin-6. J. Affect. Disord. 2010, 120:231-234.
4. Braun N., Michel U., Ernst B.P., Metzner R., Bitsch A., Weber F., Rieckmann P. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci. Lett. 1996, 215:75-78.
5. Calati R., Crisafulli C., Balestri M., Serretti A., Spina E., Calabrò M., Sidoti A., Albani D., Massat I., Höfer P., Amital D., Juven-Wetzler A., Kasper S., Zohar J., Souery D., Montgomery S., Mendlewicz J. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2013, 44:271-278.
6. Calcagni E., Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann. N. Y. Acad. Sci. 2006, 1069:62-76.
7. Caraci F., Bosco P., Signorelli M., Spada R.S., Cosentino F.I., Toscano G., Bonforte C., Muratore S., Prestianni G., Panerai S., Giambirtone M.C., Gulotta E., Romano C., Salluzzo M.G., Nicoletti F., Copani A., Drago F., Aguglia E., Ferri R. The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression. Eur. Neuropsychopharmacol. 2012, 22:281-289.
8. Cerri A.P., Arosio B., Viazzoli C., Confalonieri R., Vergani C., Annoni G. The -308 (G/A) single nucleotide polymorphism in the TNF-alpha gene and the risk of major depression in the elderly. Int. J. Geriatr. Psychiatry 2010, 25:219-223.
9. Cesari M., Penninx B.W., Newman A.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrrell K., Rubin S.M., Ding J., Simonsick E.M., Harris T.B., Pahor M. Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation 2003, 108:2317-2322.
10. Clerici M., Arosio B., Mundo E., Cattaneo E., Pozzoli S., Dell'osso B., Vergani C., Trabattoni D., Altamura A.C. Cytokine polymorphisms in the pathophysiology of mood disorders. CNS Spectr. 2009, 14:419-425.
11. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann. N. Y. Acad. Sci. 2001, 933:222-234.
12. Dhabhar F.S., Burke H.M., Epel E.S., Mellon S.H., Rosser R., Reus V.I., Wolkowitz O.M. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J. Psychiatr. Res. 2009, 43:962-969.
13. Dobolyi A., Vincze C., Pál G., Lovas G. The neuroprotective functions of transforming growth factor beta proteins. Int. J. Mol. Sci. 2012, 13:8219-8258.
14. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctôt K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
15. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) Gene on IL-6 transcription and plasma IL-6 levels, and an association with system-onset juvenile chronic arthritis. J. Clin. Investig. 1998, 102:1369-1376.
16. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
17. Himmerich H., Fulda S., Linseisen J., Seiler H., Wolfram G., Himmerich S., Gedrich K., Kloiber S., Lucae S., Ising M., Uhr M., Holsboer F., Pollmächer T. Depression, comorbidities and the TNF-alpha system. Eur. Psychiatry 2008, 23:421-429.
18. Jun T.Y., Pae C.U., Hoon-Han Chae J.H., Bahk W.M., Kim K.S., Serretti A. Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population. Psychiatr. Genet. 2003, 13:179-181.
19. Kim Y.K., Hong J.P., Hwang J.A., Lee H.J., Yoon H.K., Lee B.H., Jung H.Y., Hahn S.W., Na K.S. TNF-alpha -308G > A polymorphism is associated with suicide attempts in major depressive disorder. J. Affect. Disord. 2013, 150:668-672.
20. Lee K.M., Kim Y.K. The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder. Int. Immunopharmacol. 2006, 6:1298-1304.
21. Lee H.Y., Kim Y.K. Transforming growth factor-beta1 and major depressive disorder with and without attempted suicide: preliminary study. Psychiatry Res. 2010, 178:92-96.
22. Maes M. A Review on the Acute Phase Response in Major Depression 1993, 4:407-416.
23. Maes M., Scharpé S., Meltzer H.Y., Bosmans E., Suy E., Calabrese J., Cosyns P. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res. 1993, 49:11-27.
24. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., Desnyder R. Increased Plasma Concentrations of Interleukin-6, Soluble Interleukin-6, Soluble Interleukin-2 and Transferrin Receptor in Major Depression 1995, 18:301-309.
25. Maes M., Song C., Lin A., De Jongh R., Van Gastel A., Kenis G., Bosmans E., De Meester I., Benoy I., Neels H., Demedts P., Janca A., Scharpé S., Smith R.S. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 1998, 10:313-318.
26. Maes M., Song C., Lin A.H., Bonaccorso S., Kenis G., De Jongh R., Bosmans E., Scharpé S. Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 1999, 20:370-379.
27. Meira-Lima I.V., Pereira A.C., Mota G.F., Floriano M., Araújo F., Mansur A.J., Krieger J.E., Vallada H. Analysis of a polymorphism in the promoter region of the tumor necrosis factor alpha gene in schizophrenia and bipolar disorder: further support for an association with schizophrenia. Mol. Psychiatry 2003, 8:718-720.
28. Mihailova S., Ivanova M., Mihaylova A., Quin L., Mikova O., Naumova E. Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients. J. Neuroimmunol. 2005, 168:138-143.
29. Misener V.L., Gomez L., Wigg K.G., Luca P., King N., Kiss E., Daróczi G., Kapornai K., Tamas Z., Mayer L., Gádoros J., Baji I., Kennedy J.L., Kovacs M., Vetró A., Barr C.L. International consortium for childhood-onset mood disorders. cytokine genes TNF, IL1A, IL1B, IL6, IL1RN and IL10, and childhood-onset mood disorders. Neuropsychobiology 2008, 58:71-80.
30. Myint A.M., Leonard B.E., Steinbusch H.W., Kim Y.K. Th1, Th2, and Th3 cytokine alterations in major depression. J. Affect. Disord. 2005, 88:167-173.
31. Omrani M.D., Bushehri B., Bagheri M., Salari-Lak S., Alipour A., Anoshae M.R., Massomi R. Role of IL-10 -1082, IFN-gamma +874, and TNF-alpha -308 genes polymorphisms in suicidal behavior. Arch. Suicide Res. 2009, 13:330-339.
32. Pandey G.N., Rizavi H.S., Ren X., Fareed J., Hoppensteadt D.A., Roberts R.C., Conley R.R., Dwivedi Y. Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J. Psychiatr. Res. 2012, 46:57-63.
33. Papanicolaou D.A., Wilder R.L., Manolagas S.C., Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 1998, 128:127-137.
34. Perrey C., Pravica V., Sinnott P.J., Hutchinson I.V. Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical report. Transpl. Immunol. 1998, 6:193-197.
35. Perry V.H. Stress primes microglia to the presence of systemic inflammation: implications for environmental influences on the brain. Brain Behav. Immun. 2007, 21:45-46.
36. Pravica V., Perrey C., Stevens A., Lee J.H., Hutchinson I.V. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum. Immunol. 2000, 61:863-866.
37. Reichenberg A., Wiesner J., Weidemeyer C., Dreiseidler E., Sanderbrand S., Altincicek B., Beck E., Schlitzer M., Jomaa H. Cytokine-associated emotional and cognitive disturbances in humans. Bioorg. Med. Chem. Lett. 2001, 11:833-835.
38. Roque S., Correia-Neves M., Mesquita A.R., Palha J.A., Sousa N. Interleukin-10: A key cytokine in depression?. Cardiovasc. Psychiatry Neurol. 2009, 10:419-421.
39. Saigo K., Akutsu N., Maruyama M., Otsuki K., Hasegawa M., Aoyama H., Matsumoto I., Asano T., Kenmochi T. Study of transforming growth factor-β1 gene, mRNA, and protein in Japanese renal transplant recipients. Transplant. Proc. 2014, 46:372-375.
40. Sayed S.K., Galal S.H., Herdan O.M., Mahran A.M. Single nucleotide polymorphism T869C of transforming growth factor-beta 1 gene and systemic lupus erythematosus: association with disease susceptibility and lupus nephritis. Egypt. J. Immunol. 2014, 21:9-21.
41. Seidel A., Arolt V., Hunstiger M., Rink L., Behnisch A., Kirchner H. Cytokine production and serum proteins in depression. Scand. J. Immunol. 1995, 41:534-538.
42. Shelton R.C., Claiborne J., Sidoryk-Wegrzynowicz M., Reddy R., Aschner M., Lewis D.A., Mirnics K. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol. Psychiatry 2011, 16:751-762.
43. Surendar J., Mohan V., Rao M.M., Babu S., Aravindhan V. Increased levels of both Th1 and Th2 cytokines in subjects with metabolic syndrome (CURES-103). Diabetes Technol. Ther. 2011, 13:477-482.
44. Tonelli L.H., Stiller J., Rujescu D., Giegling I., Schneider B., Maurer K., Schnabel A., Möller H.J., Chen H.H., Postolache T.T. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr. Scand. 2008, 117:198-206.
45. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene. Eur. J. Immunogenet. 1997, 24:1-8.
46. Turner C.A., Thompson R.C., Bunney W.E., Schatzberg A.F., Barchas J.D., Myers R.M., Akil H., Watson S.J. Front. Hum. Neurosci. 2014, 8:238.
47. Yamada Y., Miyauchi A., Goto J., Takagi Y., Okuizumi H., Kanematsu M., Hase M., Takai H., Harada A., Ikeda K. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J. Bone Miner. Res. 1998, 13:1569-1576.
48. Yokota M., Ichihara S., Lin T.L., Nakashima N., Yamada Y. Association Of A T29- > C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000, 101:2783-2787. http://b16.